← Open Payments lookup

ZAHIDA SAIRITUPA: Open Payments

NPI 1831120674 · DANBURY, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,131 in 169 payments from 17 companies in 2025. Trend: 2023 $3,794 · 2024 $4,235 · 2025 $4,131

Food & beverage: $4,131
CompanyPaymentsAmount
ABBVIE INC.49$871
Neurocrine BioSciences, Inc.16$620
Teva Pharmaceuticals USA, Inc.15$478
Otsuka America Pharmaceutical, Inc.30$411
Otsuka Pharmaceutical Development & Commercialization, Inc.5$312
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)8$269
Axsome Therapeutics, Inc.6$237
Janssen Pharmaceuticals, Inc8$203
Corium, LLC11$199
Takeda Pharmaceuticals U.S.A., Inc.5$169

Products named: VRAYLAR, INGREZZA, CAPLYTA, REXULTI, Auvelity, INVEGA SUSTENNA, AUSTEDO XR, Azstarys.

Industry payments across CT — which companies pay providers there.